Working... Menu

ALRN-6924 in Patients With Advanced Solid Tumors or Lymphomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02264613
Recruitment Status : Unknown
Verified June 2017 by Aileron Therapeutics.
Recruitment status was:  Recruiting
First Posted : October 15, 2014
Last Update Posted : June 27, 2017
Information provided by (Responsible Party):
Aileron Therapeutics

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : January 2018
  Estimated Study Completion Date : July 2018